Author:
Tran-Duy An,Boonen Annelies,van de Laar Mart A. F. J.,Severens Johan L.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379–90.
2. Boonen A, Mau W. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:S112–7.
3. Franke LC, Ament AJHA, van de Laar MAFJ, Boonen A, Severens JL. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:S118–23.
4. Dougados M, Dijkmans B, Khan M, Maksymowych W, van der linden S, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis. 2002;61:iii40–50.
5. Braun J, Baraliakos X, Brandt J, Listing J, Zink A, Alten R, Burmester G, Gromnica-Ihle E, Kellner H, Schneider M, Sӧrensen H, Zeidler H, Sieper J. Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. Rheumatology. 2005;44:670–6.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献